
BayBG backs €5m series-B for Dynamic Biosensors
Bayerische Beteiligungsgesellschaft (BayBG) has taken part in a €5m series-B funding round for Martinsried-based medical devices developer Dynamic Biosensors.
Previous investors Bayern Kapital and UnternehmerTUM Venture Capital Partners also took part in the round.
The fresh capital will be used to broaden the product portfolio as well as stepping up marketing and sales activity.
Previous funding
Bayern Kapital and UnternehmerTUM took part in Dynamic Biosensor's first funding round alongside life sciences investor BioMag and German family offices in February 2013.
Company
Dynamic Biosensors is a medical devices developer, founded in 2012 and headquartered in Martinsried. The company develops sensors for the analysis of proteins and testing of new drugs. It has additional offices in Betchton (UK), Paris, San Diego, Tokyo and Singapore. It was originally founded as a spinout from the technical university of Munich.
People
Dynamic Biosensors – Frank Fischer, Wolfgang Kaiser, Ulrich Rant, Dirk Scholl, Ralf Strasse (founders).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater